Sunshine Biopharma Inc. Quarterly Nonoperating Income (Expense) in USD from Q1 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Sunshine Biopharma Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2012 to Q3 2024.
  • Sunshine Biopharma Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $124K, a 26.7% decline year-over-year.
  • Sunshine Biopharma Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $776K, a 24.1% increase year-over-year.
  • Sunshine Biopharma Inc. annual Nonoperating Income (Expense) for 2023 was $674K, a 37.7% increase from 2022.
  • Sunshine Biopharma Inc. annual Nonoperating Income (Expense) for 2022 was $490K.
  • Sunshine Biopharma Inc. annual Nonoperating Income (Expense) for 2021 was -$10M, a 353% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $776K $124K -$45.2K -26.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-05
Q2 2024 $822K $430K +$231K +116% Apr 1, 2024 Jun 30, 2024 10-Q/A 2024-08-20
Q1 2024 $591K $89.1K -$83.7K -48.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-20
Q4 2023 $674K $133K +$48.6K +57.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $626K $169K -$92K -35.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 $718K $199K +$42.5K +27.1% Apr 1, 2023 Jun 30, 2023 10-Q/A 2024-08-20
Q1 2023 $675K $173K +$186K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-20
Q4 2022 $490K $84.6K -$862K -91.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $1.35M $261K +$3.8M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$2.45M $157K +$2.65M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$5.1M -$12.9K +$4.9M +99.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$10M $947K +$1.69M Oct 1, 2021 Dec 31, 2021 10-K 2023-04-04
Q3 2021 -$11.7M -$3.54M -$2.91M -461% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$8.77M -$2.49M -$1.71M -220% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 -$7.06M -$4.91M -$4.85M -8580% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 -$2.21M -$740K -$594K -407% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-21
Q3 2020 -$1.61M -$631K -$484K -328% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$1.13M -$779K -$714K -1106% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$415K -$56.6K +$21.7K +27.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 -$436K -$146K +$35.5K +19.5% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-30
Q3 2019 -$472K -$148K +$476K +76.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$948K -$64.6K +$4.64K +6.71% Apr 1, 2019 Jun 30, 2019 10-Q/A 2020-08-31
Q1 2019 -$953K -$78.2K +$20.7K +20.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-18
Q4 2018 -$974K -$182K -$132K -268% Oct 1, 2018 Dec 31, 2018 10-K 2020-05-01
Q3 2018 -$841K -$624K -$590K -1746% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$251K -$69.2K -$56K -423% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-15
Q1 2018 -$195K -$98.9K -$12.2K -14.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-20
Q4 2017 -$183K -$49.3K +$739K +93.7% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-12
Q3 2017 -$922K -$33.8K +$1.44M +97.7% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-16
Q2 2017 -$2.36M -$13.2K -$3.23K -32.3% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-17
Q1 2017 -$2.35M -$86.7K +$149K +63.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-22
Q4 2016 -$2.5M -$788K -$324K -69.9% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 -$2.18M -$1.47M -$1.38M -1537% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-15
Q2 2016 -$799K -$10K +$139K +93.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-11
Q1 2016 -$939K -$236K -$66.1K -39% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q4 2015 -$873K -$464K -$479K -3175% Oct 1, 2015 Dec 31, 2015 10-K 2017-04-17
Q3 2015 -$394K -$89.8K -$86.3K -2523% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$307K -$149K -$54K -56.6% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-16
Q1 2015 -$253K -$170K -$74.2K -77.8% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$179K $15.1K +$15.5K Oct 1, 2014 Dec 31, 2014 10-K 2016-03-25
Q3 2014 -$195K -$3.42K -$3.05K -813% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-04
Q2 2014 -$192K -$95.4K -$95K -25335% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 -$96.5K -$95.4K +$459K +82.8% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 -$555K -$375 Oct 1, 2013 Dec 31, 2013 10-K 2015-03-11
Q3 2013 -$375 Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 -$375 Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-12
Q1 2013 -$554K -$554K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q1 2012 -$16* Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.